Tonix Pharmaceuticals Holding Corp. (TNXP) › Cost of RevenueTonix Pharmaceuticals Holding Corp. (TNXP) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2023: $4.74M2024: $7.76M2025: $6.64M$6.64M2023Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$6.64M-14.5%2024$7.76M+63.8%2023$4.74M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share